Anxiety and Treatment Adherence Among Glaucoma Patients During Covid-19 Pandemic and Earthquakes in Croatia

Gacina, Dina Lesin; Jandroković, Sonja; Marčinko, Darko; Škegro, Ivan; Pauk, Sania Vidas; Tomić, Martina; Škegro, Bernarda; Kutija, Marija Barišić; Ivkić, Petra Kristina

doi:10.24869/psyd.2022.348

Cited by 5 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To effectively treat glaucoma, regular follow-ups, choice of treatment strategy, taking into account IOP, VF, and adherence, are necessary. Decreased adherence in patients with glaucoma due to the pandemic has been previously reported [9][10][11][12][13]. Adherence in this study was possibly lower, as in previous reports, for patients with worsened MD values.…”

Section: Resultssupporting

confidence: 79%

“…Japan approved a special measure allowing prescriptions to be sent remotely during the COVID-19 pandemic, allowing treatment continuation without running out of eye drops. However, patient adherence has reportedly worsened during that period [9][10][11][12][13]. This study aimed to retrospectively investigate the impact of hospital visit interruptions and the progression of visual eld impairment in patients with glaucoma, during the COVID-19 pandemic, using data from medical records.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Glaucoma progression due to refraining examination amid the pandemic of COVID-19

Inoue,

Shiokawa,

Kunimatsu-Sanuki

et al. 2024

Int Ophthalmol

View full text Add to dashboard Cite

Some patients refrain from seeking an ophthalmologist due to the anxiety and morbidity associated with the coronavirus disease 2019 (COVID-19) pandemic. We investigated progressive visual eld defects in patients with glaucoma who refrained from ophthalmological examinations. MethodsWe retrospectively analyzed data from 886 patients with glaucoma who visited Inouye Eye Hospital in June 2022 and were followed-up prior to January 2020. We examined the number of times patients canceled visits between January 2020 and May 2022 due to coronavirus concerns. We assessed the mean deviation (MD) values of the Humphrey Visual Field Assessment (HFA) program 30 − 2 SITA Standard values after visit interruptions for worsening beyond the MD values predicted by the MD slope.Factors in uencing this difference were analyzed using logistic regression analysis. ResultsThe study included 374 men and 512 women. The mean age was 68.7 ± 12.0 years. Visit interruptions occurred in 146 patients (16.5%), with 95 (65.1%) rescheduling once, 27 (18.5%) twice, and 24 (16.4%) three or more times. Among 90 patients who underwent HFA regularly, 50 (55.6%) experienced worsethan-expected MD values and 12 (13.3%) deteriorated by 2 dB or more. Longer interruptions and high intraocular pressure before interruption worsened the MD values by 2 dB or more. ConclusionsPatients with glaucoma with visit interruptions due to the pandemic should be monitored for the progression of visual eld impairment.

show abstract

Section: Resultssupporting

confidence: 79%

Section: Introductionmentioning

confidence: 99%

Glaucoma progression due to refraining examination amid the pandemic of COVID-19

Inoue,

Shiokawa,

Kunimatsu-Sanuki

et al. 2024

Int Ophthalmol

View full text Add to dashboard Cite

show abstract

“…9 Scientific evidence reveals that the presence of depression and anxiety can cause deficits in motivation and impair adherence to treatment for different diseases. 15,[77][78][79][80][81] In this study, however, the opposite was observed. A significant relationship was found between higher levels of depression and anxiety and increased adherence.…”

contrasting

confidence: 75%

Motivational Interviewing as a Tool to Increase Motivation and Adherence to a Long COVID Telerehabilitation Intervention: Secondary Data Analysis from a Randomized Clinical Trial

León-Herrera,

Oliván-Blázquez,

Samper-Pardo

et al. 2024

PRBM

View full text Add to dashboard Cite

Background Although motivational interviewing was originally developed to address abuse disorders, scientific evidence confirms that it is an increasingly used and effective approach in a wide range of therapeutic interventions. To date, however, no studies have analyzed the use of this tool in patients with persistent symptoms following coronavirus disease 2019, a condition known as Long COVID. Purpose To analyze the effectiveness of motivational interviewing with regard to the adherence to telerehabilitation for Long COVID using a mobile application. As a secondary objective, factors related to greater motivation before and after the motivational interviewing techniques were analyzed. Patients and Methods This longitudinal design substudy used a sample of 52 adult patients with Long COVID participating in the intervention group of a randomized clinical trial. This trial examined the effectiveness of a telerehabilitation program for this population using a mobile application. This program included three motivational interviews to achieve maximum treatment adherence. In this study, the main variables were motivation and adherence to application use. Sociodemographic and clinical data, personal constructs, and affective state were also collected. Subsequently, a descriptive, correlational, and regression statistical analysis was performed using the SPSS Statistics program. Results The median motivation prior to the first motivational interview was 8 (IQR 2), the median at the end of the last motivational interview was 8.5 (IQR 2.75), and the change in motivation levels after the three motivational interviews was 0.5 (IQR 1). Affective state and final motivation scores were predictors of greater adherence to telerehabilitation treatment. Conclusion A high level of motivation after participating in motivational interviewing appears to be related to higher levels of adherence to telerehabilitation in patients with Long COVID. This suggests that motivational interviewing may be an effective tool in the treatment of this disease.

show abstract

“…There is evidence that the COVID-19 pandemic decreased quality of life metrics among those with eye disease, including increased fear about losing vision [ 16 , 17 ]. Further, the pandemic is thought to have increased the prevalence of anxiety which may have had a negative effect on treatment adherence among glaucoma patients in Croatia [ 18 ]. However, the extent to which the pandemic may have affected other factors of mental health among glaucoma patients is not well characterized.…”

Section: Introductionmentioning

confidence: 99%

Mental health and social support among glaucoma patients enrolled in the NIH All of Us COVID-19 Participant Experience (COPE) survey

Delavar

Saseendrakumar

et al. 2023

BMC Ophthalmol

View full text Add to dashboard Cite

Background The COVID-19 pandemic created many challenges for our society. In this study, we explore how measures of mental health, coping strategies, and social support during the pandemic varied by glaucoma status. Methods A cohort of patients aged 40 and over enrolled in the NIH All of Us Research Program, a nationwide longitudinal cohort, who answered the COVID-19 Participant Experience (COPE) survey was obtained. We analyzed several measures of mental health, coping strategies, and social support used during the early stages of the COVID-19 pandemic. Surveys were recurring and answered from May 2020 to February 2021. Demographics and the most recently answered survey responses were obtained and stratified by glaucoma status. Pearson’s Chi-squared tests and multivariable logistic regressions adjusting for age, gender, race, ethnicity, and income were used to generate p-values, odds ratios (ORs) and 95% confidence intervals (CIs) between outcome measures and glaucoma status. Results Of 42,484 patients who responded to All of Us COPE survey items, 2912 (6.9%) had a diagnosis of glaucoma. On Pearson’s Chi-squared tests glaucoma patients were less likely to report drinking alcohol (P = 0.003), eating more food than usual (P = 0.004), and using marijuana (P = 0.006) to cope with social distancing than those without a diagnosis of glaucoma. Further, glaucoma patients had lower rates of probable mild, moderate, or severe depression as calculated by Patient Health Questionnaire-9 (PHQ-9) scores (P < 0.001) and had lower rates of reporting some or a lot of stress from social distancing (P < 0.001). However, glaucoma patients were less likely to report having someone to help prepare meals (P = 0.005) or help with daily chores (P = 0.003) if they became sick with COVID-19. In multivariable logistic regression analyses adjusting for confounding factors, no differences were found for measures of mental health or social support. Conclusions Glaucoma patients did not fare worse on many measures of mental health and coping strategies during the early stages of the COVID-19 pandemic compared those without glaucoma. However, a substantial proportion of glaucoma patients still endorsed stress, social isolation, and probable depression, representing challenges for disease management.

show abstract

Anxiety and Treatment Adherence Among Glaucoma Patients During Covid-19 Pandemic and Earthquakes in Croatia

Cited by 5 publications

References 0 publications

Glaucoma progression due to refraining examination amid the pandemic of COVID-19

Glaucoma progression due to refraining examination amid the pandemic of COVID-19

Motivational Interviewing as a Tool to Increase Motivation and Adherence to a Long COVID Telerehabilitation Intervention: Secondary Data Analysis from a Randomized Clinical Trial

Mental health and social support among glaucoma patients enrolled in the NIH All of Us COVID-19 Participant Experience (COPE) survey

Contact Info

Product

Resources

About